TrialJournal of immunotherapy (Hagerstown, Md. : 1997)2015

Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients.

Susann Szmania et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.